Horizon’s Saint John Regional Hospital to become Canada’s first to adopt Subtle Medical’s AI solutions

Subtle Medical, a healthcare technology company using artificial intelligence to improve medical imaging, announced today the first commercial adoption of SubtlePET™ in Canada to help improve the quality and efficiency of PET imaging.

The launch was made possible by support from the Saint John Regional Hospital Foundation, a charitable organization focused on providing exceptional health care in New Brunswick.

Through the Foundation’s Medical Competition, funding was made available for the adoption of Subtle Medical’s deep learning technology, SubtlePET™, which earned recognition after demonstrating the ability to dramatically improve patient comfort and safety during medical imaging by giving imaging institutions the ability to restore image quality to standard of care when conducting shorter and lower dose PET exams.

“Our doctors and healthcare workers are constantly looking for ways to bring medical innovation and new clinical programs to life. They are backed by an ambitious and progressive foundation that’s continually striving to support them by investing in healthcare innovation for the benefit of all New Brunswickers. We look forward to seeing these new innovations in practice,” says Jamie Gallagher, President & CEO for the Foundation.

Shorter scan times are particularly beneficial to children and patients who experience pain and anxiety during these procedures. Reducing scan times could also allow institutions to schedule more patients a day on their existing scanners, resulting in shorter wait times for patients in critical need of medical imaging.

“The launch of Subtle’s AI solutions is one step further in supporting Horizon’s goal of prioritizing patient-centered care,” said Zach Kilburn, Regional Director of Diagnostic Imaging for Horizon Health Network. “The SubtlePET technology not only improves patient experience during procedures, but also allows us to see more patients, creating a better, more efficient imaging program at our center.”

“We are grateful for the support from The Saint John Regional Hospital Foundation and proud that Horizon Health Network is the first to use Subtle Medical’s AI solutions in Canada,” said Josh Gurewitz, Chief Commercial Officer at Subtle Medical. “The Canadian healthcare system is among the best in the world, so it’s only natural that hospitals and medical centers recognize the critical role AI plays in improving healthcare inefficiencies and providing the highest level of care to their patients.”

Hot this week

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.